Arch Venture Corp
Latest statistics and disclosures from ARCH Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MAZE, BEAM, RAPP, LYEL, VIR, and represent 87.85% of ARCH Venture Management's stock portfolio.
- Added to shares of these 1 stock: TXG (+$12M).
- Started 1 new stock position in TXG.
- Reduced shares in these 1 stock: CERO.
- Sold out of its position in CERO.
- ARCH Venture Management was a net buyer of stock by $12M.
- ARCH Venture Management has $652M in assets under management (AUM), dropping by 32.36%.
- Central Index Key (CIK): 0001274403
Tip: Access up to 7 years of quarterly data
Positions held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 9 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Maze Therapeatics (MAZE) | 26.2 | $171M | 4.1M | 41.43 |
|
|
| Beam Therapeutics (BEAM) | 19.3 | $126M | 4.5M | 27.72 |
|
|
| Rapport Therapeutics (RAPP) | 17.4 | $113M | 3.7M | 30.34 |
|
|
| Lyell Immunopharma Com New (LYEL) | 13.0 | $85M | 2.8M | 30.78 |
|
|
| Vir Biotechnology (VIR) | 12.0 | $78M | 13M | 6.03 |
|
|
| Erasca (ERAS) | 6.3 | $41M | 11M | 3.72 |
|
|
| Gossamer Bio (GOSS) | 3.8 | $25M | 8.1M | 3.10 |
|
|
| 10x Genomics Cl A Com (TXG) | 1.8 | $12M | NEW | 738k | 16.31 |
|
| Q32 Bio (QTTB) | 0.2 | $1.1M | 321k | 3.32 |
|
Past Filings by ARCH Venture Management
SEC 13F filings are viewable for ARCH Venture Management going back to 2018
- ARCH Venture Management 2025 Q4 filed Feb. 17, 2026
- ARCH Venture Management 2025 Q3 filed Nov. 14, 2025
- ARCH Venture Management 2025 Q2 filed Aug. 14, 2025
- ARCH Venture Management 2025 Q1 filed May 15, 2025
- ARCH Venture Management 2024 Q4 filed Feb. 14, 2025
- ARCH Venture Management 2024 Q3 filed Nov. 14, 2024
- ARCH Venture Management 2024 Q2 filed Aug. 14, 2024
- ARCH Venture Management 2024 Q1 filed May 15, 2024
- ARCH Venture Management 2023 Q4 filed Feb. 14, 2024
- ARCH Venture Management 2023 Q3 filed Nov. 14, 2023
- ARCH Venture Management 2023 Q2 filed Aug. 9, 2023
- ARCH Venture Management 2023 Q1 filed May 15, 2023
- ARCH Venture Management 2022 Q4 filed Feb. 14, 2023
- ARCH Venture Management 2022 Q3 filed Nov. 10, 2022
- ARCH Venture Management 2022 Q2 filed Aug. 15, 2022
- ARCH Venture Management 2022 Q1 restated filed May 27, 2022